• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimizing the Risk-Benefit Balance of Thromboprophylaxis in Critically Ill Patients With Coronavirus Disease 2019.

作者信息

Piagnerelli Michaël, Cauchie Philippe, Wautrecht Jean-Claude

机构信息

Intensive Care, CHU-Charleroi Marie-Curie, Université Libre de Bruxelles, Charleroi, Belgium, and Experimental Medicine Laboratory, CHU-Charleroi, ULB 222 Unit, Université Libre de Bruxelles, Brussels, Belgium.

Clinical Biology, Department of Haematology, CHU-Charleroi Marie-Curie, Université Libre de Bruxelles, Charleroi, Belgium.

出版信息

Crit Care Med. 2020 Oct;48(10):e988-e989. doi: 10.1097/CCM.0000000000004509.

DOI:10.1097/CCM.0000000000004509
PMID:32706558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7375185/
Abstract
摘要

相似文献

1
Optimizing the Risk-Benefit Balance of Thromboprophylaxis in Critically Ill Patients With Coronavirus Disease 2019.优化2019冠状病毒病重症患者血栓预防的风险效益平衡
Crit Care Med. 2020 Oct;48(10):e988-e989. doi: 10.1097/CCM.0000000000004509.
2
COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?新冠病毒肺炎：为重症患者的血栓预防开启新范式？
Crit Care. 2020 Jun 11;24(1):332. doi: 10.1186/s13054-020-03052-9.
3
Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?2019冠状病毒病的血栓预防：抗Xa因子——缺失的因素？
Am J Respir Crit Care Med. 2020 Aug 1;202(3):455-457. doi: 10.1164/rccm.202005-1654LE.
4
Hospital-based use of thromboprophylaxis in patients with COVID-19.基于医院的新型冠状病毒肺炎患者血栓预防用药情况
Lancet. 2020 May 2;395(10234):e75. doi: 10.1016/S0140-6736(20)30926-0. Epub 2020 Apr 21.
5
Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.静脉血栓栓塞症及其与 COVID-19 的关联：仍存在争议。
Medicina (Kaunas). 2020 Sep 27;56(10):506. doi: 10.3390/medicina56100506.
6
[Venous thromboembolism in patients with COVID-19].[新型冠状病毒肺炎患者的静脉血栓栓塞症]
Ugeskr Laeger. 2020 Jun 1;182(23).
7
Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).2019冠状病毒病（SARS-CoV-2感染）患者的静脉血栓栓塞——德国血管病学会（DGA）立场文件
Vasa. 2020 Jun;49(4):259-263. doi: 10.1024/0301-1526/a000885. Epub 2020 Jun 5.
8
Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.接受预防性抗凝治疗的新冠肺炎住院患者的静脉血栓栓塞症
Mayo Clin Proc. 2020 Oct;95(10):2291-2293. doi: 10.1016/j.mayocp.2020.08.014. Epub 2020 Aug 13.
9
[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].[阿根廷COVID-19住院患者血栓预防用药建议]
Medicina (B Aires). 2020;80 Suppl 3:65-66.
10
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?新冠病毒感染中的肺栓塞或肺血栓形成？使用高剂量肝素进行血栓预防的建议是否合理？
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.

引用本文的文献

1
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
2
What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?我们对危重症患者的血栓预防及其监测了解多少？
Biomedicines. 2021 Jul 22;9(8):864. doi: 10.3390/biomedicines9080864.
3
Estimation of Admission D-dimer Cut-off Value to Predict Venous Thrombotic Events in Hospitalized COVID-19 Patients: Analysis of the SEMI-COVID-19 Registry.基于 SEMI-COVID-19 登记研究的新冠肺炎住院患者入院 D-二聚体截断值预测静脉血栓栓塞事件的评估。
J Gen Intern Med. 2021 Nov;36(11):3478-3486. doi: 10.1007/s11606-021-07017-8. Epub 2021 Jul 21.
4
Have we improved the management of COVID-19 patients admitted in intensive care between the two waves?在两波疫情期间，我们对重症监护病房收治的新冠患者的管理是否有所改善？
J Crit Care. 2021 Oct;65:84-85. doi: 10.1016/j.jcrc.2021.05.022. Epub 2021 Jun 5.
5
The authors reply.作者回复。
Crit Care Med. 2020 Oct;48(10):e989-e990. doi: 10.1097/CCM.0000000000004530.

本文引用的文献

1
Coagulopathy of Coronavirus Disease 2019.新型冠状病毒疾病的凝血功能障碍。
Crit Care Med. 2020 Sep;48(9):1358-1364. doi: 10.1097/CCM.0000000000004458.
2
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.严重 COVID-19 高凝状态下常规静脉血栓栓塞预防可能不足。
Crit Care Med. 2020 Sep;48(9):e783-e790. doi: 10.1097/CCM.0000000000004466.
3
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
4
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
5
COVID-19 cytokine storm: the interplay between inflammation and coagulation.新型冠状病毒肺炎细胞因子风暴：炎症与凝血之间的相互作用
Lancet Respir Med. 2020 Jun;8(6):e46-e47. doi: 10.1016/S2213-2600(20)30216-2. Epub 2020 Apr 27.